Nasdaq and the CME Group have stepped up a joint effort to give big investors a single, regulated way to measure crypto markets. According to Nasdaq, the firms have reintroduced the Nasdaq Crypto Index as the Nasdaq-CME Crypto Index (NCI), a benchmark built to support products like ETFs and structured funds. The announcement was made early this month and is presented as a move to bring clearer rules and governance to index-based crypto exposure.
Nasdaq And CME Combine Index Expertise
Reports have disclosed the NCI will be calculated by CF Benchmarks and overseen by joint committees that include representatives from both exchanges. That arrangement is intended to mirror traditional index practices used in equities and derivatives, with regular reconstitution and transparent methodology. CF Benchmarks has already handled Nasdaq Crypto Index reconstitutions, including the reconstitution on December 1, 2025, which is part of the index family’s work ahead of the rebrand.
What The Exchanges Say
CME’s public materials describe the move as part of an expanded collaboration that links Nasdaq’s indexing work with CME’s regulated trading platform. The CME website also highlights plans for more product and contract activity tied to crypto, and it points to the ability to support markets that operate around the clock. Based on those reports, the aim is to give institutional managers a benchmark they can use when building regulated products.
Index For Diversified Crypto Exposure
According to news releases and market reporting, the Nasdaq-CME Index is not limited to a single token. The index tracks a basket of major coins so that a product tied to it would offer diversified exposure rather than a single-asset bet. Market outlets picked up the story quickly; several trading and financial news sites published pieces within days of the announcement, noting the index name change and the partners’ shared governance approach.
Operational And Timing Details
Nasdaq has also updated its market data listings to reflect name changes tied to the index family, with some effective dates scheduled later in January 2026. That timing suggests the firms plan a phased rollout: first the naming and governance alignment, then data and product support for issuers and market makers. The reconstitution timetable from CF Benchmarks shows the operational work has already been underway since December 2025.
Featured image from Unsplash, chart from TradingView
